The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Nov. 16, 2007
Applicants:

Mark Donovan, Berville, FR;

Dominique Bernard, Paris, FR;

Isabelle Castiel, Nice, FR;

Veronique Chaussade, Paris, FR;

Inventors:

Mark Donovan, Berville, FR;

Dominique Bernard, Paris, FR;

Isabelle Castiel, Nice, FR;

Veronique Chaussade, Paris, FR;

Assignee:

L'OREAL, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/68 (2006.01); A61K 8/60 (2006.01); A61K 8/66 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01); C12N 5/071 (2010.01); C12Q 1/68 (2006.01); G01N 33/50 (2006.01); A61K 38/46 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6881 (2013.01); A61K 8/606 (2013.01); A61K 8/66 (2013.01); A61K 38/465 (2013.01); A61Q 19/007 (2013.01); A61Q 19/08 (2013.01); C12N 5/0629 (2013.01); C12Q 1/6883 (2013.01); C12Y 301/2601 (2013.01); G01N 33/5082 (2013.01); G01N 33/6893 (2013.01); C12N 2501/70 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/922 (2013.01); G01N 2500/00 (2013.01); G01N 2800/20 (2013.01);
Abstract

The present invention relates to the use, in cosmetics and in therapeutics, of at least one antimicrobial protein belonging to the ribonuclease family, ribonuclease 7, or of polypeptides derived from said protein, notably as a marker for evaluating the condition of the epidermis. It further relates to the use of at least one polypeptide according to the invention, of at least one nucleic acid sequence coding for a polypeptide according to the invention, or of at least one agent that modulates the expression or the activity, notably biological, of said polypeptide or of its interaction with an element of the extracellular matrix, for the preparation of compositions intended for the prevention and/or treatment of skin disorders.


Find Patent Forward Citations

Loading…